Search Ontology:
ChEBI
alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
- Term ID
- CHEBI:42528
- Synonyms
-
- 2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-galactopyranose
- 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-2-deoxy-beta-D-galactopyranose
- 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranose
- 2-acetamido-3-O-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-2-deoxy-beta-D-galactopyranose
- alpha-D-GalNAc-(1->3)-beta-D-GalNAc
- alphaGalNAc(1->3)betaGalNAc
- beta-D-galactopyranose, 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-2-deoxy-
- FORSMANN ANTIGEN
- Forssman disaccharide
- GalNAca1-3GalNAcb
- N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosamine
- Definition
- An α-D-GalpNAc-(1→3)-D-GalpNAc having β-configuration at the reducing end anomeric centre.
- References
-
- glygen:G97834OQ
- glytoucan:G97834OQ
- pdb-ccd:FSM
- pubmed:17431391
- pubmed:17652409
- pubmed:19443021
- pubmed:25568069
- pubmed:2856907
- pubmed:31537530
- pubmed:3257757
- pubmed:36988069
- pubmed:6704310
- pubmed:7521740
- pubmed:7696844
- pubmed:7696847
- pubmed:7819593
- pubmed:8125993
- pubmed:9846499
- reaxys:7800092
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
Phenotype where environments contain alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
Phenotype modified by environments containing alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
Phenotype affecting alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
Human Disease Model